126 related articles for article (PubMed ID: 1336475)
1. Effect of enalapril treatment and sclerotherapy of esophageal varices on hepatic hemodynamics in portal hypertension.
Svoboda P; Ochmann J; Kantorová I
Hepatogastroenterology; 1992 Dec; 39(6):549-52. PubMed ID: 1336475
[TBL] [Abstract][Full Text] [Related]
2. [The ACE inhibitor, enalapril, in portal hypertension. A prospective placebo controlled study].
Svoboda P; Ochmann J; Kantorová I; Sefr R
Cas Lek Cesk; 1992 Mar; 131(6):170-3. PubMed ID: 1586932
[TBL] [Abstract][Full Text] [Related]
3. [Is it possible to predict a decrease in portal pressure after administration of ACE inhibitors?].
Svoboda P; Kantorová I; Ochmann J
Vnitr Lek; 1994 Mar; 40(3):170-3. PubMed ID: 8184570
[TBL] [Abstract][Full Text] [Related]
4. [The long-term effect of molsidomine on frequency of hemorrhage, portal and cardiac hemodynamics in patients with liver cirrhosis--a pilot study].
Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
Leber Magen Darm; 1993 May; 23(3):114-8, 121-2. PubMed ID: 8326815
[TBL] [Abstract][Full Text] [Related]
5. [Endoscopic sclerotization of esophageal varices and nitrates in the treatment of portal hypertension with bleeding esophageal varices].
Drazná E; Jedlicka J; Petrtýl J; Cervinka J; Vrana J
Sb Lek; 1991 Oct; 93(9-10):301-7. PubMed ID: 1821463
[TBL] [Abstract][Full Text] [Related]
6. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
Sookoian S; Castaño G; García SI; Viudez P; González C; Pirola CJ
Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
[TBL] [Abstract][Full Text] [Related]
7. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
Lotterer E; Wengert A; Fleig WE
Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
[TBL] [Abstract][Full Text] [Related]
10. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
[TBL] [Abstract][Full Text] [Related]
11. The influence of endoscopic variceal ligation on the portal pressure gradient in cirrhotics.
Pereira-Lima JC; Zanette M; Lopes CV; de Mattos AA
Hepatogastroenterology; 2003; 50(49):102-6. PubMed ID: 12630002
[TBL] [Abstract][Full Text] [Related]
12. [Emergency sclerotherapy in esophageal varices bleeding: prospective study in unselected patients with portal hypertension].
Szczepanik AB; Misiak A; Meissner AJ
Pol Merkur Lekarski; 2007 May; 22(131):354-6. PubMed ID: 17679366
[TBL] [Abstract][Full Text] [Related]
13. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H
Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibitors and sclerotherapy on portal hemodynamics in patients with portal hypertension.
Nasr AA; el-Hak NG; Settein ME; Khafagy MA; Tadros MT
Hepatogastroenterology; 2000; 47(33):795-806. PubMed ID: 10919035
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
16. [Influence of the sclerosing of esophageal varices on portal pressure and azygos venous blood flow].
Bourbon P; Zarski JP; Kitmacher P; Bourlard P; Machecourt J; Denis B; Rachail M
Gastroenterol Clin Biol; 1990; 14(3):244-7. PubMed ID: 2344911
[TBL] [Abstract][Full Text] [Related]
17. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C
J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921
[TBL] [Abstract][Full Text] [Related]
18. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between hemodynamic parameters of the portal circulation in cirrhotic patients].
Bretagne JF; Bourguet P; Morisot D; Duvauferrier R; Darnault P; Gastard J
Gastroenterol Clin Biol; 1985 Oct; 9(10):674-8. PubMed ID: 4065489
[TBL] [Abstract][Full Text] [Related]
20. Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics.
Graffeo M; Buffoli F; Lanzani G; Donato F; Cesari P; Benedini D; Rolfi F; Paterlini A
Am J Gastroenterol; 1994 Oct; 89(10):1815-22. PubMed ID: 7942674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
